Corcept asks FDA to OK experimental Cushing's therapy relacorilant
Corcept Therapeutics' application is based on data from several clinical trials that tested relacorilant in people with Cushing’s syndrome.| Cushing's Disease News
Corcept Therapeutics' application is based on data from several clinical trials that tested relacorilant in people with Cushing’s syndrome.| Cushing's Disease News
Marisa Wexler is a senior science writer for Cushing's Disease News with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of Cushing's disease topics.| Cushing's Disease News
Long-term cognitive issues in Cushing's may occur because high cortisol levels can cause changes in brain structure, a study found.| Cushing's Disease News
Category archive page for News.| Cushing's Disease News
